Recombinant COVID-19 antigen-human soluble ACE2 protein
(soluble hACE2, extracellular hACE2, C-FC)
Cat No.: GMP-H-ACE2002
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Package||Catalog No.||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Source (Expression Host)||mammalian (human cell)|
Recombinant human soluble ACE2 protein (ACE2,Angiotensin-converting enzyme 2) was expressed |
in mammalian cell (human cells)expression system with a His tag at the C-terminus. The target
gene encoding 723 amino acids (Gln18-Ser740) of human ACE2 extracellular domain is expressed with
human Fc tag at the C-terminus.
|Bioactivity validation||Spike(S-RBD) protein binding|
spike protein-hACE2 binding inhibition assay used in neutralizing antibody, |
peptide inhibitor, lead compounds and vaccines development against COVID-19
|predicted Molecular Mass||109.2kD|
|Formulation||Lyophilized from sterile PBS, PH 7.4|
|Storage||Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.|
GeneMedi's Spike protein & ACE2-Fc Binding Validation In Sandwich ELISA
Figure. GeneMedi's ACE2-Fc(GMP-H-ACE2002) binding validation with Spike protein (GMP-V-2019nCoV-SRBD001) and (GMP-V-2019nCoV-S1S2001) in sandwich ELISA.